Listing clarity: what early-stage issuers need to know about ASX’s Guidance Note 1 update
ASX’s 16 May 2025 Compliance Update No. 05/25, effective 30 May 2025 lightens the path to IPO for emerging tech, biotech, and medical-technology entities. By formally embedding its admission criteria, ASX provides guidance which will reduce the opacity of the key features under consideration for IPO applicants about to undertake the in-principle review process. Here’s […]
Fast-track to the ASX: ASIC’s streamlined IPO review
On 10 June 2025, ASIC announced a two-year trial of a streamlined IPO process designed to shorten listing timetables and improve deal certainty. The move is in response to a steady decline in new listings, as companies increasingly turn to private capital to avoid the prolonged exposure to market risks under the current IPO framework. […]
Real Estate Markets Quarterly – June 2025
The real estate sector is navigating a transformative period, with shifting interest rates, evolving regulations, and heightened focus on sustainability and privacy. Are you prepared for what lies ahead? In this edition of our Real Estate Quarterly, we dive into the pressing legal issues reshaping the real estate landscape, from compliance with work health and […]
